Invention Grant
- Patent Title: Therapy and prevention of prion protein complex infections in non-human animals
-
Application No.: US16921666Application Date: 2020-07-06
-
Publication No.: US11213532B2Publication Date: 2022-01-04
- Inventor: Joshua O. Atiba , Steven C. Sereboff
- Applicant: Joshua O. Atiba , Steven C. Sereboff
- Applicant Address: US CA Watsonville; US CA Santa Barbara
- Assignee: Joshua O. Atiba,Steven C. Sereboff
- Current Assignee: Joshua O. Atiba,Steven C. Sereboff
- Current Assignee Address: US CA Watsonville; US CA Santa Barbara
- Agency: Socal IP Law Group LLP
- Agent Brian S. Tamsut
- Main IPC: A61K31/65
- IPC: A61K31/65 ; A61P33/00 ; A61K9/00 ; A61K31/436 ; A61P31/00 ; A61K45/06 ; A61P37/06 ; A61P31/04

Abstract:
There are disclosed therapies and preventions of prion protein complex infections. The transcription of the amyloid precursor protein gene and PrP gene and the RNA transcript are the rate-limiting steps and are most susceptible for blockage and control of the process of amyloid protein formation and PrPsc formation. Thus, therapies and prevention regimes for prion protein complex infections interrupt this process at the level of DNA transcription to RNA, RNA transport to the mitochondrion for protein synthesis and deposition in the cerebral cortex neurons.
Public/Granted literature
- US20200330490A1 THERAPY AND PREVENTION OF PRION PROTEIN COMPLEX INFECTIONS IN NON-HUMAN ANIMALS Public/Granted day:2020-10-22
Information query